Found: 31
Select item for more details and to access through your institution.
Characterisation of a hand-held CZT-based gamma camera for 177Lu imaging.
- Published in:
- EJNMMI Physics, 2020, v. 7, n. 1, p. 1, doi. 10.1186/s40658-020-00313-y
- By:
- Publication type:
- Article
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 12, p. 1930, doi. 10.1038/s41416-023-02462-0
- By:
- Publication type:
- Article
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266991
- By:
- Publication type:
- Article
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [<sup>177</sup>Lu]Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1070, doi. 10.2967/jnumed.123.266991
- By:
- Publication type:
- Article
Dosimetric quantities of neuroendocrine tumors over treatment cycles with<sup> 177</sup>Lu-DOTA-TATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262069
- By:
- Publication type:
- Article
Dosimetric quantities of neuroendocrine tumors over treatment cycles with <sup>177</sup>Lu-DOTA-TATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262069
- By:
- Publication type:
- Article
Dosimetric quantities of neuroendocrine tumors over treatment cycles with <sup>177</sup>Lu-DOTA-TATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262069
- By:
- Publication type:
- Article
Dosimetric quantities of neuroendocrine tumors over treatment cycles with <sup>177</sup>Lu-DOTA-TATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262069
- By:
- Publication type:
- Article
Dosimetric quantities of neuroendocrine tumors over treatment cycles with <sup>177</sup>Lu-DOTA-TATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262069
- By:
- Publication type:
- Article
Bone marrow absorbed doses and correlations with hematological response during <sup>177</sup>Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.225235
- By:
- Publication type:
- Article
A prospective observational study to evaluate the effects of long-acting somatostatin analogs on <sup>68</sup>Ga-DOTATATE uptake in patients with neuroendocrine tumors.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.226332
- By:
- Publication type:
- Article
Bone Marrow Absorbed Doses and Correlations with Hematologic Response During <sup>177</sup>Lu-DOTATATE Treatments Are Influenced by Image-Based Dosimetry Method and Presence of Skeletal Metastases.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 10, p. 1406, doi. 10.2967/jnumed.118.225235
- By:
- Publication type:
- Article
Long-Term Retention of <sup>177</sup>Lu/<sup>177m</sup>Lu-DOTATATE in Patients Investigated by γ-Spectrometry and γ-Camera Imaging.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 7, p. 976, doi. 10.2967/jnumed.115.155390
- By:
- Publication type:
- Article
A method for tumor dosimetry based on hybrid planar‐SPECT/CT images and semiautomatic segmentation.
- Published in:
- Medical Physics, 2018, v. 45, n. 11, p. 5004, doi. 10.1002/mp.13178
- By:
- Publication type:
- Article
The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab.
- Published in:
- Oncologist, 2011, v. 16, n. 2, p. 136, doi. 10.1634/theoncologist.2010-0154
- By:
- Publication type:
- Article
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 5, p. 431, doi. 10.1080/0284186X.2023.2212411
- By:
- Publication type:
- Article
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 10, p. 1284, doi. 10.3109/0284186X.2014.941999
- By:
- Publication type:
- Article
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres.
- Published in:
- Endocrine (1355008X), 2022, v. 75, n. 3, p. 856, doi. 10.1007/s12020-021-02952-2
- By:
- Publication type:
- Article
AI-based quantification of whole-body tumour burden on somatostatin receptor PET/CT.
- Published in:
- European Journal of Hybrid Imaging, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41824-023-00172-7
- By:
- Publication type:
- Article
Feasibility of simplifying renal dosimetry in <sup>177</sup>Lu peptide receptor radionuclide therapy.
- Published in:
- EJNMMI Physics, 2018, v. 5, n. 1, p. 1, doi. 10.1186/s40658-018-0210-2
- By:
- Publication type:
- Article
Correction to: Impact of Specific Bowel Symptoms on Quality of Life in Patients with Midgut Neuroendocrine Tumours.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Impact of Specific Bowel Symptoms on Quality of Life in Patients with Midgut Neuroendocrine Tumours.
- Published in:
- World Journal of Surgery, 2021, v. 45, n. 9, p. 2793, doi. 10.1007/s00268-021-06146-9
- By:
- Publication type:
- Article
Health-Related Quality of Life After Surgery for Small Intestinal Neuroendocrine Tumours.
- Published in:
- World Journal of Surgery, 2018, v. 42, n. 10, p. 3231, doi. 10.1007/s00268-018-4638-2
- By:
- Publication type:
- Article
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based <sup>177</sup>Lu-DOTATATE treatment of NET patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 11, p. 3830, doi. 10.1007/s00259-022-05786-w
- By:
- Publication type:
- Article
Individualised Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 9, p. 1480, doi. 10.1007/s00259-017-3678-4
- By:
- Publication type:
- Article
Optimal follow‐up with somatostatin receptor PET/CT imaging in patients with small intestinal neuroendocrine tumours.
- Published in:
- Journal of Neuroendocrinology, 2024, v. 36, n. 8, p. 1, doi. 10.1111/jne.13396
- By:
- Publication type:
- Article
Relationship between somatostatin receptor expressing tumour volume and health‐related quality of life in patients with metastatic GEP‐NET.
- Published in:
- Journal of Neuroendocrinology, 2022, v. 34, n. 6, p. 1, doi. 10.1111/jne.13139
- By:
- Publication type:
- Article
Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms.
- Published in:
- Journal of Neuroendocrinology, 2021, v. 33, n. 5, p. 1, doi. 10.1111/jne.12967
- By:
- Publication type:
- Article
SPECT image segmentation for estimation of tumour volume and activity concentration in Lu-DOTATATE radionuclide therapy.
- Published in:
- EJNMMI Research, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13550-017-0262-7
- By:
- Publication type:
- Article
Pituitary Function after High-Dose <sup>177</sup>Lu-DOTATATE Therapy and Long-Term Follow-Up.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 4, p. 344, doi. 10.1159/000507761
- By:
- Publication type:
- Article
Relationships between uptake of [<sup>68</sup>Ga]Ga-DOTA-TATE and absorbed dose in [<sup>177</sup>Lu]Lu-DOTA-TATE therapy.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00947-2
- By:
- Publication type:
- Article